bioAffinity Technologies, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-15.1M | — |
| FY2021 | — | $-15.8M | $1.4M |
| FY2022 | — | $11.0M | $11.4M |
| FY2023 | — | $4.9M | $2.8M |
| FY2024 | — | $2.6M | $1.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-15.1M | — |
| FY2021 | — | $-15.8M | $1.4M |
| FY2022 | — | $11.0M | $11.4M |
| FY2023 | — | $4.9M | $2.8M |
| FY2024 | — | $2.6M | $1.1M |